Reactions Weekly

, Volume 1761, Issue 1, pp 3–3 | Cite as

Losartan-containing tablets recalled due to NMBA impurity

News item


  1. US Food and Drug Administration. Macleods Pharmaceutical Limited Issues Voluntary Nationwide Consumer Level Recall of Losartan Potassium 50mg and Losartan Potassium/Hydrochlorothiazide combination Tablets 50mg/12.5mg, 100mg/12.5mg and 100mg/25mg due to detection of NMBA (N-Nitroso-N Methyl-4-aminobutyric acid) Impurity. Internet Document : 26 Jun 2019. Available from: URL:

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations